Loading university
Jin Wang — Dr. Jin Wang's lab focuses on developing new cancer treatments by targeting specific proteins in cells. The team studies how these proteins influence immune responses in cancer therapy, particularly in the context of experimental treatments that could make current therapies more effective. By investigating the role of RIPK1 — a protein that affects cell survival and immune signaling — they aim to create new drugs that help patients who do not respond to existing cancer immunotherapies.
Martin M. Matzuk — Dr. Martin M. Matzuk's lab at Baylor College of Medicine focuses on innovative areas of reproductive biology, particularly in developing new male contraceptives and therapeutic options for conditions like endometriosis. The lab uses advanced drug discovery techniques to target specific proteins called kinases, which play crucial roles in fertility and reproductive health. By exploring these biological processes, the lab aims to create effective non-hormonal contraceptives and medications that improve women's health outcomes, especially for those suffering from endometriosis.
Hugo J Bellen — Dr. Hugo J. Bellen's lab focuses on using genomic medicine to help underserved populations, particularly those unable to afford DNA testing for rare diseases. The research team combines expertise from various fields to identify and study new disease genes, utilizing advanced techniques like whole-exome sequencing and model organisms like fruit flies. The ultimate goal is to improve diagnostics and care for individuals with rare genetic disorders while also contributing to broader genomic knowledge.
Margaret A. Goodell — Dr. Margaret A. Goodell's lab focuses on understanding clonal hematopoiesis (CH), a pre-cancerous condition where certain blood cells expand due to genetic mutations. The lab investigates how different stressors, like inflammation and environmental factors, interact with these mutations to influence the risk of developing blood cancers. By using innovative mouse models and analyzing data from large human studies, their aim is to identify modifiable factors that could prevent the progression of CH into malignancies.
Fritz J Sedlazeck — Dr. Fritz J. Sedlazeck's lab at Baylor College of Medicine focuses on improving the understanding of complex regions in the human genome, particularly those that impact cardiovascular disease risk. The lab develops innovative graph genome methods to analyze medically relevant genes, which will help identify genetic variants associated with diseases. Their work utilizes extensive genomic data and aims to make genetic analysis accessible to a broader community, ultimately contributing to better diagnostics and therapies for various conditions.
James F Martin — Dr. James F. Martin's lab at Baylor College of Medicine focuses on understanding how specific signaling pathways in the heart can promote cell proliferation and regeneration after injury. By investigating the Hippo-YAP and Wnt signaling pathways, the lab aims to develop innovative treatments for heart failure, a leading cause of death. The research uses advanced techniques in gene therapy and cell models to find ways to enhance the heart's ability to heal itself following conditions like myocardial infarction.
Yi Li — Dr. Yi Li's lab focuses on understanding breast cancer risk factors related to childbirth and lactation, as well as developing new rat models to study estrogen receptor-positive breast cancer. They investigate how delaying pregnancy might affect women’s cancer risk, especially with regard to lactation's role in tumor development. Additionally, the lab works on characterizing new animal models to better mimic human breast cancer biology and treatment response.
Xander H.T. Wehrens — Dr. Xander H.T. Wehrens' lab at Baylor College of Medicine focuses on understanding atrial fibrillation, a common heart rhythm disorder. The team investigates the molecular mechanisms that contribute to this condition, including the roles of inflammation and specific signaling pathways that lead to abnormal heart activity. Through innovative models and techniques, their goal is to uncover new strategies for prevention and treatment of atrial fibrillation and related complications.
Pawel Stankiewicz — Dr. Pawel Stankiewicz's lab at Baylor College of Medicine focuses on understanding the genetic causes of severe lung disorders in newborns, specifically lethal lung developmental disorders like alveolar capillary dysplasia. The team investigates how specific genetic variants affect lung development and contribute to serious conditions like pulmonary arterial hypertension. Their ultimate goal is to improve diagnosis and treatment options for these disorders through a better understanding of genetic mechanisms.